Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474288 · ClinicalTrials.gov registry record
The COVID-19 PUI Reality Check (CPRC) Study
A clinical trial of Covid19 Immunology, sponsored by Bassett Healthcare.
- Completed
- Registry status
- 37
- Enrollment target
- 1
- Study location
NCT04474288 is a study of Covid19 Immunology that has completed, run by Bassett Healthcare. The registered enrollment target is 37 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04474288, a study of Covid19 Immunology, has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This study compares SARS-CoV-2 immune responses in high pretest probability swab negative hospitalized PUI patients vs. low pretest probability swab negative hospitalized APS (Asymptomatic Persons being Screened) patients to try to understand the appropriateness and safety of clinical decisions made in these patient populations based on swab results.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST SARS-CoV-2 antibody testing
Study Locations (1)
New York
- Bassett Medical Center - Cooperstown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2020-07-16 |
| Est. Completion | 2022-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474288
The ClinicalTrials.gov registry entry for NCT04474288 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bassett Healthcare, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Covid19 Immunology appearing as the primary indexed condition, and to 1 intervention - of which SARS-CoV-2 antibody testing is the first listed.
NCT04474288 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04474288 about?
NCT04474288 is a clinical study titled "The COVID-19 PUI Reality Check (CPRC) Study". This study compares SARS-CoV-2 immune responses in high pretest probability swab negative hospitalized PUI patients vs. low pretest probability swab negative hospitalized APS (Asymptomatic Persons being Screened) patients to try to understand the appropriateness and safety of clinical decisions made...
What is the current status of trial NCT04474288?
This trial is currently completed. The enrollment target is 37 participants. The study started on 2020-07-16. Estimated completion is 2022-02-28.
What conditions does trial NCT04474288 study?
This clinical trial studies the following conditions: Covid19 Immunology.
What interventions are being tested in trial NCT04474288?
The interventions under investigation include: SARS-CoV-2 antibody testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04474288?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04474288 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.